Evidence map›Paper›PMID 42006582›Full record

ArticleJournal of extracellular biology2026

ADAM10-Mediated Proteolytic Remodelling of Signalling and Adhesion Proteins on Brain Cell-Derived Small Extracellular Vesicles.

Christopher C Reimann, Hermann C Altmeppen, Tomas Koudelka, Michaela Schweizer, Andreas Tholey, Behnam Mohammadi, Julia Bär, Lesley Cheng, Markus Glatzel, Marina Mikhaylova and 1 more

Abstract read
In one paragraph

Article in Journal of extracellular biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Christopher C ReimannDepartment of Biochemistry and Chemistry, La Trobe Institute for Molecular Science La Trobe University Bundoora Victoria Australia.ORCID https://orcid.org/0000-0001-8080-0419
Hermann C AltmeppenInstitute of Neuropathology University Medical Center Hamburg-Eppendorf (UKE) Hamburg Germany.ORCID https://orcid.org/0000-0001-9439-6533
Tomas KoudelkaInstitute of Experimental Medicine Christian-Albrechts-Universität zu Kiel Kiel Germany.ORCID https://orcid.org/0009-0008-2895-6051
Michaela SchweizerCore Facility Morphology and Electron Microscopy, Center for Molecular Neurobiology University Medical Center Hamburg-Eppendorf (UKE) Hamburg Germany.ORCID https://orcid.org/0000-0001-5062-328X
Andreas TholeyInstitute of Experimental Medicine Christian-Albrechts-Universität zu Kiel Kiel Germany.ORCID https://orcid.org/0000-0002-8687-6817
Behnam MohammadiInstitute of Neuropathology University Medical Center Hamburg-Eppendorf (UKE) Hamburg Germany.ORCID https://orcid.org/0000-0002-9178-3949
Julia BärGuest Group 'Neuronal Protein Transport', Center for Molecular Neurobiology University Medical Center Hamburg-Eppendorf (UKE) Hamburg Germany.ORCID https://orcid.org/0000-0002-0954-2776
Lesley ChengDepartment of Biochemistry and Chemistry, La Trobe Institute for Molecular Science La Trobe University Bundoora Victoria Australia.ORCID https://orcid.org/0000-0002-8075-6144
Markus GlatzelInstitute of Neuropathology University Medical Center Hamburg-Eppendorf (UKE) Hamburg Germany.ORCID https://orcid.org/0000-0002-7720-8817
Marina MikhaylovaGuest Group 'Neuronal Protein Transport', Center for Molecular Neurobiology University Medical Center Hamburg-Eppendorf (UKE) Hamburg Germany.ORCID https://orcid.org/0000-0001-7646-1346
Andrew F HillInstitute for Health and Sport Victoria University Melbourne Australia.ORCID https://orcid.org/0000-0001-5581-2354

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Proteases are common components of extracellular vesicles (EVs), yet the extent and functional relevance of ongoing proteolytic activity on EV surfaces remain largely unexplored. Such activity could significantly influence EV function and identity, with likely implications for EV-mediated signalling, recipient cell targeting, cargo delivery, and even translational applications ranging from biomarker discovery to therapeutic approaches. Here, we investigated the impact of sustained proteolysis on the composition of brain cell-derived EVs, focusing on A Disintegrin And Metalloprotease 10 (ADAM10), a key sheddase for signalling and adhesion proteins involved in neuronal and synaptic processes. Using primary rat cortical cultures, we found that numerous known ADAM10 substrates are part of small EVs (sEVs), and that their associated functions overlap with major sEV-mediated roles such as nervous system development, cell adhesion, and neurite outgrowth. Applying N-terminal proteomics to monitor sEV-derived cleavage fragments over time, we identified novel substrate candidates and demonstrated that sEV-associated ADAM10 activity remodels surface proteins involved in EV-cell interactions while generating soluble factors implicated in neuronal development. These findings suggest a previously unrecognised role for ADAM10 as a modulator of sEV composition and potentially cell-targeting specificity in the brain and position EVs as dynamic platforms for proteolytic processing 'on the move'.

Indexed as

ADAM10ectodomain sheddingextracellular vesiclesintercellular communicationneurobiologyprion proteinproteomics

Identifiers

PMID42006582
PMCPMC13088879

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.